Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations

This study has been completed.
Alcon Research
Information provided by:
Robin, Alan L., M.D.
ClinicalTrials.gov Identifier:
First received: August 29, 2007
Last updated: July 21, 2009
Last verified: July 2009
This study will be used to evaluate how patients put eye drops in their eyes and any problems that may arise from this activity. The information gathered will help identify common problems patients are having with putting in their eye medications. Then doctors can be better informed about the issues and provide better advice to their patients to overcome these problems.

Dry Eye Syndrome

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Evaluation of Eye Drop Administration in Glaucoma Patients

Resource links provided by NLM:

Further study details as provided by Robin, Alan L., M.D.:

Enrollment: 200
Study Start Date: February 2007
Study Completion Date: July 2007
Detailed Description:

Approximately 100 patients will take part in a one time procedure and survey as part of this project. After appropriate consent patients are asked to complete a short 2 page survey about themselves and their eye drops. Then a video recording will be made of the patient instilling eye drops in their habitual manner. The eye drops used will be sterile saline placed in either Travatan-like or Systane bottles to simulate the corresponding prescribed medication. The videos will be graded for instillation technique and combined with scoring of survey answers.

Patients will be asked to instill the drops to their left eye with their dominant hand as we expect this to be most difficult. Patients with severe (>20/200) vision loss will instill drops into their better seeing eye.


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
173 subjects enrolled and 222 video recordings were made. Ages ranged from 21-94 years old (mean:67 yrs) and subjects were 55% female and 70% caucasian.

Inclusion Criteria:

  • Currently using topical glaucoma medications
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00522600

United States, Maryland
ALan L Robin MD PA
Baltimore, Maryland, United States, 21209
Sponsors and Collaborators
Robin, Alan L., M.D.
Alcon Research
Principal Investigator: Jennifer L Stone, OD Alan L Robin MD PA
Study Director: Alan L Robin, MD Alan L Robin MD PA
  More Information

Additional Information:
No publications provided by Robin, Alan L., M.D.

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jennifer L. Stone, OD, Glaucoma Specialists
ClinicalTrials.gov Identifier: NCT00522600     History of Changes
Other Study ID Numbers: SI0717
Study First Received: August 29, 2007
Last Updated: July 21, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Robin, Alan L., M.D.:
glaucoma medications

Additional relevant MeSH terms:
Dry Eye Syndromes
Keratoconjunctivitis Sicca
Conjunctival Diseases
Corneal Diseases
Eye Diseases
Lacrimal Apparatus Diseases
Ocular Hypertension

ClinicalTrials.gov processed this record on November 25, 2015